Given our data in MSA, future studies should examine whether SCD inhibition provides similar modulation for oligodendrocytes with α‐synuclein aggregates as seen in MS or in neurons with α‐synuclein aggregates in PD. This evidence concerns the gene SCD and Parkinson disease.